Hanan Lamlum

• Oncoprotein Bcl-2 and microsatellite instability are associated with disease-free survival and treatment response in colorectal cancer.

  Journal article

  Bendardaf R. et al, (2008), Oncol Rep, 20, 999 - 1004

• Thymidylate synthase and microsatellite instability in colorectal cancer: implications for disease free survival, treatment response and survival with metastases.

  Journal article

  Bendardaf R. et al, (2008), Acta Oncol, 47, 1046 - 1053

• Thymidylate synthase expression in primary colorectal tumours is correlated with its expression in metastases.

  Journal article

  Bendardaf R. et al, (2007), Scand J Gastroenterol, 42, 471 - 476

• Mismatch repair status is a predictive factor of tumour response to 5-fluorouracil and irinotecan chemotherapy in patients with advanced colorectal cancer.

  Journal article

  Bendardaf R. et al, (2007), Tumour Biol, 28, 212 - 220

• Comparison of CD44 expression in primary tumours and metastases of colorectal cancer.

  Journal article

  Bendardaf R. et al, (2006), Oncol Rep, 16, 741 - 746

• E-cadherin expression pattern in primary colorectal carcinomas and their metastases reflects disease outcome.

  Journal article

  Elzagheid A. et al, (2006), World J Gastroenterol, 12, 4304 - 4309

• Thymidylate synthase expression levels: a prognostic and predictive role in advanced colorectal cancer.

  Journal article

  Bendardaf R. et al, (2005), Oncol Rep, 14, 657 - 662

• Nuclear area is a prognostic determinant in advanced colorectal cancer.

  Journal article

  Buhmeida A. et al, (2005), Anticancer Res, 25, 3083 - 3088

• E-cadherin, CD44s and CD44v6 correlate with tumour differentiation in colorectal cancer.

  Journal article

  Bendardaf R. et al, (2005), Oncol Rep, 13, 831 - 835

• Prognostic and predictive molecular markers in colorectal carcinoma.

  Journal article

  Bendardaf R. et al, (2004), Anticancer Res, 24, 2519 - 2530

• CD44 variant 6 expression predicts response to treatment in advanced colorectal cancer.

  Journal article

  Bendardaf R. et al, (2004), Oncol Rep, 11, 41 - 45

• Response to chemotherapy (irinotecan plus 5-fluorouracil) in colorectal carcinoma can be predicted by tumour DNA content.

  Journal article

  Bendardaf R. et al, (2004), Oncology, 66, 46 - 52

• Refining the relation between 'first hits' and 'second hits' at the APC locus: the 'loose fit' model and evidence for differences in somatic mutation spectra among patients.

  Journal article

  Crabtree M. et al, (2003), Oncogene, 22, 4257 - 4265

• Low collagenase-1 (MMP-1) and MT1-MMP expression levels are favourable survival markers in advanced colorectal carcinoma.

  Journal article

  Bendardaf R. et al, (2003), Oncology, 65, 337 - 346

• Apoptotic index and bcl-2 expression as prognostic factors in colorectal carcinoma.

  Journal article

  Bendardaf R. et al, (2003), Oncology, 64, 435 - 442

• Analysis of chromosomal instability in human colorectal adenomas with two mutational hits at APC.

  Journal article

  Sieber OM. et al, (2002), Proc Natl Acad Sci U S A, 99, 16910 - 16915

• Mutation cluster region, association between germline and somatic mutations and genotype-phenotype correlation in upper gastrointestinal familial adenomatous polyposis.

  Journal article

  Groves C. et al, (2002), Am J Pathol, 160, 2055 - 2061

• Germline mutations in FH predispose to dominantly inherited uterine fibroids, skin leiomyomata and papillary renal cell cancer.

  Journal article

  Tomlinson IP. et al, (2002), Nat Genet, 30, 406 - 410

• Whole-gene APC deletions cause classical familial adenomatous polyposis, but not attenuated polyposis or "multiple" colorectal adenomas

  Journal article

  Sieber OM. et al, (2002), PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 99, 2954 - 2958

• Whole-gene APC deletions cause classical familial adenomatous polyposis, but not attenuated polyposis or "multiple" colorectal adenomas.

  Journal article

  Sieber OM. et al, (2002), Proc Natl Acad Sci U S A, 99, 2954 - 2958

• Erratum: The adenomatous polyposis coli (APC) tumour suppressor-genetics, function and disease (molecular medicine today 6(462-469))

  Journal article

  Sieber OM. et al, (2000), Trends in Molecular Medicine, 7

• The adenomatous polyposis coli (APC) tumour suppressor--genetics, function and disease.

  Journal article

  Sieber OM. et al, (2000), Mol Med Today, 6, 462 - 469

• Germline APC variants in patients with multiple colorectal adenomas, with evidence for the particular importance of E1317Q.

  Journal article

  Lamlum H. et al, (2000), Hum Mol Genet, 9, 2215 - 2221

• APC mutations in sporadic colorectal tumors: A mutational "hotspot" and interdependence of the "two hits".

  Journal article

  Rowan AJ. et al, (2000), Proc Natl Acad Sci U S A, 97, 3352 - 3357

• The androgen receptor exon 1 trinucleotide repeat does not act as a modifier of the age of presentation in breast cancer.

  Journal article

  Given HF. et al, (2000), Eur J Cancer, 36, 533 - 534

• APC mutations are sufficient for the growth of early colorectal adenomas.

  Journal article

  Lamlum H. et al, (2000), Proc Natl Acad Sci U S A, 97, 2225 - 2228

Recent Publications

• Oncoprotein Bcl-2 and microsatellite instability are associated with disease-free survival and treatment response in colorectal cancer.

  Journal article

  Bendardaf R. et al, (2008), Oncol Rep, 20, 999 - 1004

• Thymidylate synthase and microsatellite instability in colorectal cancer: implications for disease free survival, treatment response and survival with metastases.

  Journal article

  Bendardaf R. et al, (2008), Acta Oncol, 47, 1046 - 1053

• Thymidylate synthase expression in primary colorectal tumours is correlated with its expression in metastases.

  Journal article

  Bendardaf R. et al, (2007), Scand J Gastroenterol, 42, 471 - 476

• Mismatch repair status is a predictive factor of tumour response to 5-fluorouracil and irinotecan chemotherapy in patients with advanced colorectal cancer.

  Journal article

  Bendardaf R. et al, (2007), Tumour Biol, 28, 212 - 220

• Comparison of CD44 expression in primary tumours and metastases of colorectal cancer.

  Journal article

  Bendardaf R. et al, (2006), Oncol Rep, 16, 741 - 746